Monitoring serum HER2 levels in breast cancer patients

BACKGROUND: We have developed a new approach to reduce the serum interference for ELISA. The purpose of this study is to investigate if we can use the optimized ELISA (MBB-ELISA) to detect serum soluble HER2/neu (sHER2) in early stage primary breast cancer and monitor its change during treatments. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Tchou, Julia, Lam, Lian, Li, Yun Rose, Edwards, Claire, Ky, Bonnie, Zhang, Hongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456592/
https://www.ncbi.nlm.nih.gov/pubmed/26069876
http://dx.doi.org/10.1186/s40064-015-1015-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456592/
https://www.ncbi.nlm.nih.gov/pubmed/26069876
http://dx.doi.org/10.1186/s40064-015-1015-6

Ejemplares similares